Difficulty: Medium
Average Score: 65%
Practice
Reduction in sexual function is least seen with
Correct answer
C
Rationale
In the context of basic pharmacology principles, the reduction in sexual function is least seen with Bupropion (option C). Bupropion is an atypical antidepressant that is known to have a lower incidence of sexual side effects compared to other antidepressants such as Imipramine (option A) and Fluoxetine (option B).
Bupropion works by inhibiting the reuptake of dopamine and norepinephrine, which differentiates it from other antidepressants that primarily target serotonin. The mechanism of action of Bupropion is thought to contribute to its lower incidence of sexual side effects, making it a favorable option for individuals who may be sensitive to these adverse effects.
Imipramine, a tricyclic antidepressant, and Fluoxetine, a selective serotonin reuptake inhibitor (SSRI), are known to be associated with a higher risk of sexual dysfunction as compared to Bupropion. Tricyclic antidepressants like Imipramine can cause anticholinergic side effects that may impact sexual function, while SSRIs like Fluoxetine are commonly associated with sexual side effects such as decreased libido, delayed ejaculation, or erectile dysfunction.
In an educational context, understanding the differences in side effect profiles of various antidepressants, including their impact on sexual function, is crucial for healthcare professionals to make informed decisions when prescribing medications. It is important to consider individual patient factors, such as pre-existing sexual dysfunction or concerns, when selecting an appropriate antidepressant to optimize both therapeutic outcomes and patient quality of life.
Bupropion works by inhibiting the reuptake of dopamine and norepinephrine, which differentiates it from other antidepressants that primarily target serotonin. The mechanism of action of Bupropion is thought to contribute to its lower incidence of sexual side effects, making it a favorable option for individuals who may be sensitive to these adverse effects.
Imipramine, a tricyclic antidepressant, and Fluoxetine, a selective serotonin reuptake inhibitor (SSRI), are known to be associated with a higher risk of sexual dysfunction as compared to Bupropion. Tricyclic antidepressants like Imipramine can cause anticholinergic side effects that may impact sexual function, while SSRIs like Fluoxetine are commonly associated with sexual side effects such as decreased libido, delayed ejaculation, or erectile dysfunction.
In an educational context, understanding the differences in side effect profiles of various antidepressants, including their impact on sexual function, is crucial for healthcare professionals to make informed decisions when prescribing medications. It is important to consider individual patient factors, such as pre-existing sexual dysfunction or concerns, when selecting an appropriate antidepressant to optimize both therapeutic outcomes and patient quality of life.